Basic information
Biomarker: CA724
Histology type: endometrial carcinoma
Cohort characteristics
Country: China
Region: Zhengzhou
Study type: prospective study
Followed up time :
Subgroup 1 name : EC
Subgroup 1 number: 105
Subgroup 2 name: healthy
Subgroup 2 number: 87
| Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
|---|---|---|---|---|---|---|---|---|
| 192 | EC | 105 | healthy | 87 |
Sample information
Conclusion: Combination of HE4, CA125, CA724, and CA19-9 has the highest value in diagnosing endometrial cancer, and they can be a useful tissue immune marker for patients with endometrial cancer.
Sample type : serum
Sample method: Roche electrochemiluminescent immunoassay
Expression pattern : Combination of HE4, CA125, CA724, and CA19-9
Expression elevation: critical values=6.9 U/mL
Disease information
Statictics: Mean ;Range
Subgroup 1 age: 54;33-71
Subgroup 2 age: 53;28-74
Related information
UniProt Link:
Molecular function from UniProt:
